Protein Description

Gene Symbol E2F1
Entrez ID 1869
Uniprot ID Q01094
Description E2F transcription factor 1
Chromosomal Location chr20: 33,675,683-33,686,404
Ontology GO ID GO Term Definition Evidence

BP

GO:0000077

DNA damage checkpoint

A cell cycle checkpoint that regulates progression through the cell cycle in response to DNA damage. A DNA damage checkpoint may blocks cell cycle progression (in G1, G2 or metaphase) or slow the rate at which S phase proceeds.

IMP

BP

GO:0000122

negative regulation of transcription from RNA polymerase II promoter

Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IMP

BP

GO:0006351

transcription, DNA-templated

The cellular synthesis of RNA on a template of DNA.

ISS

BP

GO:0006355

regulation of transcription, DNA-templated

Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.

IDA

BP

GO:0006977

DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest

A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle.

TAS

BP

GO:0007283

spermatogenesis

The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.

IEA

BP

GO:0008630

intrinsic apoptotic signaling pathway in response to DNA damage

A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.

IMP

BP

GO:0010628

positive regulation of gene expression

Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.

IDA

BP

GO:0030900

forebrain development

The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).

IEA

BP

GO:0043276

anoikis

Apoptosis triggered by inadequate or inappropriate adherence to substrate e.g. after disruption of the interactions between normal epithelial cells and the extracellular matrix.

IEA

BP

GO:0043392

negative regulation of DNA binding

Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).

IDA

BP

GO:0045599

negative regulation of fat cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.

ISS

BP

GO:0045892

negative regulation of transcription, DNA-templated

Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.

IDA|IMP

BP

GO:0045893

positive regulation of transcription, DNA-templated

Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.

IDA|IMP

BP

GO:0045944

positive regulation of transcription from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IMP

BP

GO:0048146

positive regulation of fibroblast proliferation

Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.

IMP

BP

GO:0048255

mRNA stabilization

Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules.

IDA

BP

GO:0070345

negative regulation of fat cell proliferation

Any process that stops or decreases the rate or extent of fat cell proliferation.

ISS

BP

GO:0071398

cellular response to fatty acid

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.

IEA

BP

GO:0071456

cellular response to hypoxia

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.

IEA

BP

GO:0071466

cellular response to xenobiotic stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a xenobiotic compound stimulus. Xenobiotic compounds are compounds foreign to living organisms.

IEA

BP

GO:0071930

negative regulation of transcription involved in G1/S transition of mitotic cell cycle

Any process that stop, prevents or decreases transcription as part of the G1/S transition of the mitotic cell cycle.

IMP

BP

GO:0072332

intrinsic apoptotic signaling pathway by p53 class mediator

A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, and ends when the execution phase of apoptosis is triggered.

IEA

BP

GO:1900740

positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway

Any process that activates or increases the frequency, rate or extent of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway.

TAS

BP

GO:1990086

lens fiber cell apoptotic process

Any apoptotic process in a lens fiber cell. Lens fiber cells are elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.

IEA

BP

GO:1990090

cellular response to nerve growth factor stimulus

A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus.

IEA

BP

GO:2000045

regulation of G1/S transition of mitotic cell cycle

Any cell cycle regulatory process that controls the commitment of a cell from G1 to S phase of the mitotic cell cycle.

IMP

CC

GO:0000790

nuclear chromatin

The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.

IDA

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IDA

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

TAS

CC

GO:0005739

mitochondrion

A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.

IEA

CC

GO:0035189

Rb-E2F complex

A multiprotein complex containing a heterodimeric E2F transcription factor and a Retinoblastoma (Rb) family member. This complex is capable of repressing transcription of E2F-regulated genes in order to regulate cell cycle progression.

IDA

MF

GO:0001047

core promoter binding

Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for the basal transcription machinery. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.

IDA

MF

GO:0003677

DNA binding

Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

IDA|IMP

MF

GO:0003700

transcription factor activity, sequence-specific DNA binding

Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.

IDA|TAS

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008134

transcription factor binding

Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription.

IPI

MF

GO:0019901

protein kinase binding

Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.

IEA

MF

GO:0043565

sequence-specific DNA binding

Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.

ISS

MF

GO:0046983

protein dimerization activity

The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits.

IEA

Domain ID Description

IPR003316

E2F/DP family, winged-helix DNA-binding domain

IPR011991

Winged helix-turn-helix DNA-binding domain

IPR015633

E2F Family

IPR032198

E2F transcription factor, CC-MB domain

Pathway ID Pathway Term Pathway Source

hsa01522

Endocrine resistance

KEGG

hsa04110

Cell cycle

KEGG

hsa04137

Mitophagy - animal

KEGG

hsa05161

Hepatitis B

KEGG

hsa05166

HTLV-I infection

KEGG

hsa05200

Pathways in cancer

KEGG

hsa05206

MicroRNAs in cancer

KEGG

hsa05212

Pancreatic cancer

KEGG

hsa05214

Glioma

KEGG

hsa05215

Prostate cancer

KEGG

hsa05218

Melanoma

KEGG

hsa05219

Bladder cancer

KEGG

hsa05220

Chronic myeloid leukemia

KEGG

hsa05222

Small cell lung cancer

KEGG

hsa05223

Non-small cell lung cancer

KEGG

hsa05224

Breast cancer

KEGG

WP437

EGF/EGFR Signaling Pathway

WikiPathways

WP707

DNA Damage Response

WikiPathways

WP2431

Spinal Cord Injury

WikiPathways

WP1984

Integrated Breast Cancer Pathway

WikiPathways

WP1545

miRNAs involved in DNA damage response

WikiPathways

WP3584

MECP2 and Associated Rett Syndrome

WikiPathways

WP3969

H19 action Rb-E2F1 signaling and CDK-β-catenin activity

WikiPathways

WP236

Adipogenesis

WikiPathways

WP2828

Bladder Cancer

WikiPathways

WP1530

miRNA Regulation of DNA Damage Response

WikiPathways

WP3959

DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM

WikiPathways

WP615

Senescence and Autophagy in Cancer

WikiPathways

WP45

G1 to S cell cycle control

WikiPathways

WP1971

Integrated Cancer Pathway

WikiPathways

WP2261

Signaling Pathways in Glioblastoma

WikiPathways

WP179

Cell Cycle

WikiPathways

WP2586

Aryl Hydrocarbon Receptor

WikiPathways

WP2446

Retinoblastoma (RB) in Cancer

WikiPathways

WP2032

Human Thyroid Stimulating Hormone (TSH) signaling pathway

WikiPathways

h_g1Pathway

Cell Cycle: G1/S Check Point

BioCarta

h_fbw7Pathway

Cyclin E Destruction Pathway

BioCarta

h_cellcyclePathway

Cyclins and Cell Cycle Regulation

BioCarta

h_skp2e2fPathway

E2F1 Destruction Pathway

BioCarta

h_il2rbPathway

IL-2 Receptor Beta Chain in T cell Activation

BioCarta

h_RacCycDPathway

Influence of Ras and Rho proteins on G1 to S Transition

BioCarta

h_etsPathway

METS affect on Macrophage Differentiation

BioCarta

h_p53Pathway

p53 Signaling Pathway

BioCarta

h_p27Pathway

Regulation of p27 Phosphorylation during Cell Cycle Progression

BioCarta

h_arfPathway

Tumor Suppressor Arf Inhibits Ribosomal Biogenesis

BioCarta

UMLS CUI UMLS Term

C0025202

Melanoma

C1458155

Mammary Neoplasms

C2239176

Liver Carcinoma

Tissue Cell Type

adrenal gland

glandular cells

appendix

lymphoid tissue

bone marrow

hematopoietic cells

cerebellum

cells in molecular layer

cerebellum

Purkinje cells

cerebral cortex

glial cells

cerebral cortex

neuronal cells

colon

glandular cells

esophagus

squamous epithelial cells

hippocampus

neuronal cells

lymph node

germinal center cells

lymph node

non-germinal center cells

nasopharynx

respiratory epithelial cells

parathyroid gland

glandular cells

placenta

decidual cells

placenta

trophoblastic cells

rectum

glandular cells

skin

fibroblasts

skin

epidermal cells

spleen

cells in red pulp

spleen

cells in white pulp

testis

cells in seminiferous ducts

tonsil

germinal center cells

tonsil

non-germinal center cells

vagina

squamous epithelial cells

No databases found.

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

Gene Symbol Entrez ID Uniprot ID Score

E2F3

1871

O00716

0.00

PRMT5

10419

O14744

0.25

TUBA4A

7277

P68366

0.49

CHL1

10752

O00533

0.49

NGRN

51335

Q9NPE2

0.49

CDKN1A

1026

P38936

0.52

E2F2

1870

Q14209

0.52

E2F4

1874

Q16254

0.52

ERCC3

2071

P19447

0.56

IFI16

3428

Q16666

0.56

CDK3

1018

Q00526

0.62

BIRC3

330

Q13489

0.63

CEBPD

1052

P49716

0.63

CSNK1A1

1452

P48729

0.63

ESR1

2099

P03372

0.63

FHL2

2274

Q14192

0.63

IGF1

3479

P05019

0.63

MYBL2

4605

P10244

0.63

PKIB

5570

Q9C010

0.63

SPIB

6689

Q01892

0.63

TEAD3

7005

Q99594

0.63

ASH2L

9070

Q9UBL3

0.63

RNF144A

9781

P50876

0.63

MGA

23269

Q8IWI9

0.63

UHRF2

115426

Q96PU4

0.63

DDB1

100290337

Q16531

0.63

ATAD2

29028

Q6PL18

0.68

FZR1

51343

Q9UM11

0.68

GSK3B

2932

P49841

0.72

PRMT2

3275

P55345

0.72

RBBP4

5928

Q09028

0.72

XIAP

331

P98170

0.73

CDKN2A

1029

Q8N726

0.73

ANAPC5

51433

Q9UJX4

0.73

YWHAQ

10971

P27348

0.75

NFKB1

4790

P19838

0.79

BRCA1

672

P38398

0.80

CREBBP

1387

Q92793

0.81

KAT2A

2648

Q92830

0.82

NRIP1

8204

P48552

0.84

SIRT1

23411

Q96EB6

0.85

HDAC1

3065

Q13547

0.87

CDK2

1017

P24941

0.88

MCPH1

79648

Q8NEM0

0.88

CCNA2

890

P20248

0.89

PHB

5245

P35232

0.90

SP1

6667

P08047

0.96

TFDP1

7027

Q14186

0.97

CCND1

595

P24385

0.00

CCNE2

9134

O96020

0.00

CDC6

990

Q99741

0.49

CWC27

10283

Q6UX04

0.49

UBXN1

51035

Q04323

0.49

ARID4B

51742

Q4LE39

0.49

CDK1

983

P06493

0.52

DNMT1

1786

P26358

0.52

E2F6

1876

O75461

0.52

MNAT1

4331

P51948

0.52

BTRC

8945

Q9Y297

0.52

CTDP1

9150

Q9Y5B0

0.52

SERTAD2

9792

Q14140

0.52

RBX1

9978

P62877

0.52

SENP8

123228

Q96LD8

0.52

ATM

472

Q13315

0.55

ATR

545

Q13535

0.55

CHEK2

11200

O96017

0.55

PA2G4

5036

Q9UQ80

0.56

PRDM2

7799

Q13029

0.56

STOML1

9399

Q9UBI4

0.56

TP53

7157

P04637

0.62

KDM1A

23028

O60341

0.62

BIRC2

329

Q13490

0.63

AR

367

P10275

0.63

CCNE1

898

P24864

0.63

CDC27

996

P30260

0.63

CDH1

999

P12830

0.63

KLF6

1316

Q99612

0.63

MAGEA11

4110

P43364

0.63

MOV10

4343

Q9HCE1

0.63

RBL2

5934

Q08999

0.63

SUMO1

7341

P63165

0.63

PSMD14

10213

O00487

0.63

NXF1

10482

Q9UBU9

0.63

LAMTOR5

10542

O43504

0.63

LEF1

51176

Q9UJU2

0.63

ANAPC7

51434

Q9UJX3

0.63

ANAPC11

51529

Q9NYG5

0.63

SETD7

80854

Q8WTS6

0.63

KAT5

10524

Q92993

0.65

BIN1

274

O00499

0.68

RARA

5914

P10276

0.68

VHL

7428

P40337

0.68

KDM2A

22992

Q9Y2K7

0.68

RNF126

55658

Q9BV68

0.68

CDKN2A

1029

P42771

0.70

CEBPE

1053

Q15744

0.71

HCFC1

3054

P51610

0.72

RING1

6015

Q06587

0.72

TRIM16

10626

O95361

0.72

BRMS1

25855

Q9HCU9

0.72

CDT1

81620

Q9H211

0.72

CDC20

991

Q12834

0.73

NEDD8

4738

Q15843

0.73

TRIM28

10155

Q13263

0.73

EP300

2033

Q09472

0.74

DDB2

1643

Q92466

0.75

MDM2

4193

Q00987

0.75

STAT1

6772

P42224

0.75

NCOR2

9612

Q9Y618

0.75

BTG3

10950

Q14201

0.75

PURA

5813

Q00577

0.76

MDM4

4194

O15151

0.78

PARP1

142

P09874

0.79

ARID3A

1820

Q99856

0.79

BRD2

6046

P25440

0.79

SP2

6668

Q02086

0.79

SP3

6670

Q02447

0.79

SP4

6671

Q02446

0.79

TBP

6908

P20226

0.79

TP53BP1

7158

Q12888

0.79

NCOA6

23054

Q14686

0.79

NCOA3

8202

Q9Y6Q9

0.82

CDK7

1022

P50613

0.83

KAT2B

8850

Q92831

0.83

NSMCE3

56160

Q96MG7

0.85

TRRAP

8295

Q9Y4A5

0.86

GTF2H1

2965

P32780

0.88

CUL1

8454

Q13616

0.88

CCNA1

8900

P78396

0.88

NPDC1

56654

Q9NQX5

0.88

RB1

5925

P06400

0.90

RBL1

5933

P28749

0.90

SKP2

6502

Q13309

0.90

TOPBP1

11073

Q92547

0.90

NDN

4692

Q99608

0.95

TFDP2

7029

Q14188

0.96